Literature DB >> 33064339

The genomic regulatory elements for estrogen receptor alpha transactivation-function-1 regulated genes.

Yukitomo Arao1, Katherine J Hamilton1, Sara A Grimm2, Kenneth S Korach1.   

Abstract

Estrogen receptor alpha (ERα) is a ligand-dependent transcription regulator, containing two transactivation functional domains, AF-1 and AF-2. The selective estrogen receptor modulators (SERMs), including 4-hydroxytamoxifen (4OHT), activate AF-1 preferentially rather than AF-2. However, it is unclear whether this specific function is related to the tissue-selective functionality of SERMs. Moreover, there is no information determining AF-1-dependent estrogenic-genes existing in tissues. We sought to identify AF-1-dependent estrogenic-genes using the AF-2 mutated knock-in (KI) mouse model, AF2ERKI. AF2ER is an AF-2 disrupted estradiol (E2)-insensitive mutant ERα, but AF-1-dependent transcription can be activated by the estrogen-antagonists, fulvestrant (ICI) and 4OHT. Gene profiling and ChIP-Seq analysis identified Klk1b21 as an ICI-inducible gene in AF2ERKI uterus. The regulatory activity was analyzed further using a cell-based reporter assay. The 5'-flanking 0.4k bp region of Klk1b21 gene responded as an ERα AF-1-dependent estrogen-responsive promoter. The 150 bp minimum ERα binding element (EBE) consists of three direct repeats. These three half-site sequences were essential for the ERα-dependent transactivation and were differentially recognized by E2 and 4OHT for the gene activation. This response was impaired when the minimum EBE was fused with a thymidine-kinase promoter but could be restored by fusion with the 100 bp minimum transcription initiation element (TIE) of Klk1b21, suggesting that the cooperative function of EBE and TIE is essential for mediating AF-1-dependent transactivation. These findings provide the first in vivo evidence that endogenous ERα AF-1 dominant estrogenic-genes exist in estrogen-responsive organs. Such findings will aid in understanding the mechanism of ERα-dependent tissue-selective activity of SERMs. Published 2020. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Keywords:  SERM; estrogen receptor alpha; estrogen-responsive element; tamoxifen; transactivation domain

Mesh:

Substances:

Year:  2020        PMID: 33064339      PMCID: PMC7686083          DOI: 10.1096/fj.202001435R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.834


  38 in total

1.  A far upstream estrogen response element of the ovalbumin gene contains several half-palindromic 5'-TGACC-3' motifs acting synergistically.

Authors:  S Kato; L Tora; J Yamauchi; S Masushige; M Bellard; P Chambon
Journal:  Cell       Date:  1992-02-21       Impact factor: 41.582

2.  Novel DNA motif binding activity observed in vivo with an estrogen receptor α mutant mouse.

Authors:  Sylvia C Hewitt; Leping Li; Sara A Grimm; Wipawee Winuthayanon; Katherine J Hamilton; Brianna Pockette; Cory A Rubel; Lars C Pedersen; David Fargo; Rainer B Lanz; Francesco J DeMayo; Günther Schütz; Kenneth S Korach
Journal:  Mol Endocrinol       Date:  2014-04-08

3.  Transactivation Function-2 of Estrogen Receptor α Contains Transactivation Function-1-regulating Element.

Authors:  Yukitomo Arao; Laurel A Coons; William J Zuercher; Kenneth S Korach
Journal:  J Biol Chem       Date:  2015-05-31       Impact factor: 5.157

4.  Estrogen receptor α AF-2 mutation results in antagonist reversal and reveals tissue selective function of estrogen receptor modulators.

Authors:  Yukitomo Arao; Katherine J Hamilton; Manas K Ray; Gregory Scott; Yuji Mishina; Kenneth S Korach
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-22       Impact factor: 11.205

Review 5.  Review: The angiogenic and vasodilatory utero-placental network.

Authors:  G Valdés; J Corthorn
Journal:  Placenta       Date:  2011-02-04       Impact factor: 3.481

6.  The human estrogen receptor has two independent nonacidic transcriptional activation functions.

Authors:  L Tora; J White; C Brou; D Tasset; N Webster; E Scheer; P Chambon
Journal:  Cell       Date:  1989-11-03       Impact factor: 41.582

7.  Estrogen receptor-dependent genomic responses in the uterus mirror the biphasic physiological response to estrogen.

Authors:  Sylvia Curtis Hewitt; Bonnie J Deroo; Katherine Hansen; Jennifer Collins; Sherry Grissom; Cynthia A Afshari; Kenneth S Korach
Journal:  Mol Endocrinol       Date:  2003-07-31

8.  Estrogen receptor α L543A,L544A mutation changes antagonists to agonists, correlating with the ligand binding domain dimerization associated with DNA binding activity.

Authors:  Yukitomo Arao; Katherine J Hamilton; Laurel A Coons; Kenneth S Korach
Journal:  J Biol Chem       Date:  2013-06-03       Impact factor: 5.157

9.  Maternal uterine vascular remodeling during pregnancy.

Authors:  George Osol; Lorna G Moore
Journal:  Microcirculation       Date:  2014-01       Impact factor: 2.628

10.  Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase.

Authors:  S Kato; H Endoh; Y Masuhiro; T Kitamoto; S Uchiyama; H Sasaki; S Masushige; Y Gotoh; E Nishida; H Kawashima; D Metzger; P Chambon
Journal:  Science       Date:  1995-12-01       Impact factor: 47.728

View more
  1 in total

Review 1.  The physiological role of estrogen receptor functional domains.

Authors:  Yukitomo Arao; Kenneth S Korach
Journal:  Essays Biochem       Date:  2021-12-17       Impact factor: 8.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.